nodes	percent_of_prediction	percent_of_DWPC	metapath
Thioridazine—HTR6—Raloxifene—osteoporosis	0.198	0.284	CbGbCtD
Thioridazine—CYP1A2—Estropipate—osteoporosis	0.0629	0.09	CbGbCtD
Thioridazine—CYP2C9—Estropipate—osteoporosis	0.0567	0.0811	CbGbCtD
Thioridazine—CYP2C8—Raloxifene—osteoporosis	0.0542	0.0776	CbGbCtD
Thioridazine—CYP2C8—Ethinyl Estradiol—osteoporosis	0.0524	0.0749	CbGbCtD
Thioridazine—CYP2C8—Cholecalciferol—osteoporosis	0.0419	0.0599	CbGbCtD
Thioridazine—CYP2C19—Cholecalciferol—osteoporosis	0.0351	0.0502	CbGbCtD
Thioridazine—CYP2C8—Estradiol—osteoporosis	0.0338	0.0483	CbGbCtD
Thioridazine—CYP1A2—Conjugated Estrogens—osteoporosis	0.0298	0.0426	CbGbCtD
Thioridazine—CYP2C9—Cholecalciferol—osteoporosis	0.0292	0.0418	CbGbCtD
Thioridazine—CYP2C19—Estradiol—osteoporosis	0.0283	0.0405	CbGbCtD
Thioridazine—CYP2D6—Cholecalciferol—osteoporosis	0.0267	0.0382	CbGbCtD
Thioridazine—CYP1A2—Estradiol—osteoporosis	0.0261	0.0374	CbGbCtD
Thioridazine—CYP2C9—Estradiol—osteoporosis	0.0235	0.0337	CbGbCtD
Thioridazine—Anorexia—Calcium Acetate—osteoporosis	0.00122	0.00583	CcSEcCtD
Thioridazine—Hypotension—Calcium Acetate—osteoporosis	0.00119	0.00572	CcSEcCtD
Thioridazine—Weight increased—Estropipate—osteoporosis	0.00116	0.00556	CcSEcCtD
Thioridazine—Photosensitivity reaction—Alendronate—osteoporosis	0.00114	0.00549	CcSEcCtD
Thioridazine—Lethargy—Pamidronate—osteoporosis	0.00113	0.00542	CcSEcCtD
Thioridazine—Weight increased—Raloxifene—osteoporosis	0.00112	0.00539	CcSEcCtD
Thioridazine—Decreased appetite—Calcium Acetate—osteoporosis	0.00111	0.00532	CcSEcCtD
Thioridazine—Constipation—Calcium Acetate—osteoporosis	0.00109	0.00523	CcSEcCtD
Thioridazine—Psychotic disorder—Pamidronate—osteoporosis	0.00108	0.00519	CcSEcCtD
Thioridazine—Anorexia—Ergocalciferol—osteoporosis	0.00107	0.00515	CcSEcCtD
Thioridazine—Drowsiness—Calcitriol—osteoporosis	0.00107	0.00511	CcSEcCtD
Thioridazine—Dermatitis contact—Estradiol—osteoporosis	0.00106	0.00509	CcSEcCtD
Thioridazine—Feeling abnormal—Calcium Acetate—osteoporosis	0.00105	0.00504	CcSEcCtD
Thioridazine—Lethargy—Zoledronate—osteoporosis	0.00103	0.00495	CcSEcCtD
Thioridazine—Erythema—Etidronic acid—osteoporosis	0.00103	0.00492	CcSEcCtD
Thioridazine—Asthma—Risedronate—osteoporosis	0.00101	0.00483	CcSEcCtD
Thioridazine—Oedema peripheral—Estropipate—osteoporosis	0.001	0.00482	CcSEcCtD
Thioridazine—Oedema peripheral—Alendronate—osteoporosis	0.000989	0.00475	CcSEcCtD
Thioridazine—Decreased appetite—Ergocalciferol—osteoporosis	0.000979	0.0047	CcSEcCtD
Thioridazine—Oedema peripheral—Raloxifene—osteoporosis	0.000973	0.00467	CcSEcCtD
Thioridazine—Constipation—Ergocalciferol—osteoporosis	0.000963	0.00462	CcSEcCtD
Thioridazine—Oedema peripheral—Ibandronate—osteoporosis	0.000963	0.00462	CcSEcCtD
Thioridazine—Gynaecomastia—Estradiol—osteoporosis	0.00096	0.00461	CcSEcCtD
Thioridazine—Anaemia—Etidronic acid—osteoporosis	0.000948	0.00455	CcSEcCtD
Thioridazine—Hypersensitivity—Calcium Acetate—osteoporosis	0.000939	0.00451	CcSEcCtD
Thioridazine—Weight increased—Ethinyl Estradiol—osteoporosis	0.000939	0.00451	CcSEcCtD
Thioridazine—Angioedema—Etidronic acid—osteoporosis	0.000937	0.0045	CcSEcCtD
Thioridazine—Sweating increased—Pamidronate—osteoporosis	0.000932	0.00447	CcSEcCtD
Thioridazine—Leukopenia—Etidronic acid—osteoporosis	0.000918	0.00441	CcSEcCtD
Thioridazine—Mental disorder—Estropipate—osteoporosis	0.000893	0.00429	CcSEcCtD
Thioridazine—Erythema—Estropipate—osteoporosis	0.000887	0.00426	CcSEcCtD
Thioridazine—Erythema—Alendronate—osteoporosis	0.000874	0.00419	CcSEcCtD
Thioridazine—Asthma—Zoledronate—osteoporosis	0.000874	0.00419	CcSEcCtD
Thioridazine—Diarrhoea—Calcium Acetate—osteoporosis	0.000872	0.00419	CcSEcCtD
Thioridazine—Mental disorder—Ibandronate—osteoporosis	0.000856	0.00411	CcSEcCtD
Thioridazine—Nasal congestion—Estradiol—osteoporosis	0.000855	0.0041	CcSEcCtD
Thioridazine—Arrhythmia—Calcitriol—osteoporosis	0.000855	0.0041	CcSEcCtD
Thioridazine—Sweating increased—Zoledronate—osteoporosis	0.000851	0.00408	CcSEcCtD
Thioridazine—Erythema—Ibandronate—osteoporosis	0.000851	0.00408	CcSEcCtD
Thioridazine—Confusional state—Etidronic acid—osteoporosis	0.000844	0.00405	CcSEcCtD
Thioridazine—Asthma—Conjugated Estrogens—osteoporosis	0.000841	0.00404	CcSEcCtD
Thioridazine—Erythema—Calcitriol—osteoporosis	0.000833	0.004	CcSEcCtD
Thioridazine—Pancytopenia—Zoledronate—osteoporosis	0.00083	0.00398	CcSEcCtD
Thioridazine—Sweating increased—Conjugated Estrogens—osteoporosis	0.00082	0.00393	CcSEcCtD
Thioridazine—Angioedema—Estropipate—osteoporosis	0.000811	0.00389	CcSEcCtD
Thioridazine—Vomiting—Calcium Acetate—osteoporosis	0.000811	0.00389	CcSEcCtD
Thioridazine—Anaemia—Alendronate—osteoporosis	0.000808	0.00388	CcSEcCtD
Thioridazine—Angioedema—Alendronate—osteoporosis	0.000799	0.00383	CcSEcCtD
Thioridazine—Agranulocytosis—Pamidronate—osteoporosis	0.000796	0.00382	CcSEcCtD
Thioridazine—Weight increased—Zoledronate—osteoporosis	0.000795	0.00382	CcSEcCtD
Thioridazine—Lethargy—Estradiol—osteoporosis	0.000795	0.00382	CcSEcCtD
Thioridazine—Oedema peripheral—Risedronate—osteoporosis	0.000794	0.00381	CcSEcCtD
Thioridazine—Anaemia—Ibandronate—osteoporosis	0.000786	0.00377	CcSEcCtD
Thioridazine—Angioedema—Ibandronate—osteoporosis	0.000777	0.00373	CcSEcCtD
Thioridazine—Weight increased—Conjugated Estrogens—osteoporosis	0.000766	0.00367	CcSEcCtD
Thioridazine—Agitation—Calcitriol—osteoporosis	0.000765	0.00367	CcSEcCtD
Thioridazine—Nausea—Calcium Acetate—osteoporosis	0.000757	0.00363	CcSEcCtD
Thioridazine—Agranulocytosis—Zoledronate—osteoporosis	0.000727	0.00349	CcSEcCtD
Thioridazine—Oedema—Estropipate—osteoporosis	0.000724	0.00348	CcSEcCtD
Thioridazine—Mental disorder—Ethinyl Estradiol—osteoporosis	0.000724	0.00347	CcSEcCtD
Thioridazine—Arrhythmia—Risedronate—osteoporosis	0.00072	0.00345	CcSEcCtD
Thioridazine—Constipation—Etidronic acid—osteoporosis	0.000716	0.00343	CcSEcCtD
Thioridazine—Mental disorder—Risedronate—osteoporosis	0.000706	0.00339	CcSEcCtD
Thioridazine—Feeling abnormal—Etidronic acid—osteoporosis	0.00069	0.00331	CcSEcCtD
Thioridazine—Oedema peripheral—Zoledronate—osteoporosis	0.000689	0.00331	CcSEcCtD
Thioridazine—Thrombocytopenia—Raloxifene—osteoporosis	0.000687	0.0033	CcSEcCtD
Thioridazine—Hyperhidrosis—Raloxifene—osteoporosis	0.000678	0.00325	CcSEcCtD
Thioridazine—Asthma—Estradiol—osteoporosis	0.000673	0.00323	CcSEcCtD
Thioridazine—Hyperhidrosis—Ibandronate—osteoporosis	0.000671	0.00322	CcSEcCtD
Thioridazine—Nausea—Ergocalciferol—osteoporosis	0.000669	0.00321	CcSEcCtD
Thioridazine—Erythema—Pamidronate—osteoporosis	0.000667	0.0032	CcSEcCtD
Thioridazine—Oedema peripheral—Conjugated Estrogens—osteoporosis	0.000663	0.00318	CcSEcCtD
Thioridazine—Angioedema—Ethinyl Estradiol—osteoporosis	0.000657	0.00315	CcSEcCtD
Thioridazine—Sweating increased—Estradiol—osteoporosis	0.000656	0.00315	CcSEcCtD
Thioridazine—Anaemia—Risedronate—osteoporosis	0.000648	0.00311	CcSEcCtD
Thioridazine—Anorexia—Calcitriol—osteoporosis	0.000648	0.00311	CcSEcCtD
Thioridazine—Somnolence—Estropipate—osteoporosis	0.000644	0.00309	CcSEcCtD
Thioridazine—Angioedema—Risedronate—osteoporosis	0.000641	0.00307	CcSEcCtD
Thioridazine—Arrhythmia—Zoledronate—osteoporosis	0.000625	0.003	CcSEcCtD
Thioridazine—Constipation—Estropipate—osteoporosis	0.000619	0.00297	CcSEcCtD
Thioridazine—Hypersensitivity—Etidronic acid—osteoporosis	0.000617	0.00296	CcSEcCtD
Thioridazine—Anaemia—Pamidronate—osteoporosis	0.000616	0.00296	CcSEcCtD
Thioridazine—Photosensitivity reaction—Estradiol—osteoporosis	0.000615	0.00295	CcSEcCtD
Thioridazine—Weight increased—Estradiol—osteoporosis	0.000613	0.00294	CcSEcCtD
Thioridazine—Mental disorder—Zoledronate—osteoporosis	0.000613	0.00294	CcSEcCtD
Thioridazine—Agitation—Pamidronate—osteoporosis	0.000613	0.00294	CcSEcCtD
Thioridazine—Constipation—Alendronate—osteoporosis	0.00061	0.00293	CcSEcCtD
Thioridazine—Angioedema—Pamidronate—osteoporosis	0.000609	0.00292	CcSEcCtD
Thioridazine—Erythema—Zoledronate—osteoporosis	0.000609	0.00292	CcSEcCtD
Thioridazine—Somnolence—Calcitriol—osteoporosis	0.000604	0.0029	CcSEcCtD
Thioridazine—Decreased appetite—Ibandronate—osteoporosis	0.000604	0.0029	CcSEcCtD
Thioridazine—Arrhythmia—Conjugated Estrogens—osteoporosis	0.000602	0.00289	CcSEcCtD
Thioridazine—Leukopenia—Pamidronate—osteoporosis	0.000597	0.00286	CcSEcCtD
Thioridazine—Constipation—Ibandronate—osteoporosis	0.000594	0.00285	CcSEcCtD
Thioridazine—Decreased appetite—Calcitriol—osteoporosis	0.000591	0.00284	CcSEcCtD
Thioridazine—Mental disorder—Conjugated Estrogens—osteoporosis	0.00059	0.00283	CcSEcCtD
Thioridazine—Feeling abnormal—Alendronate—osteoporosis	0.000588	0.00282	CcSEcCtD
Thioridazine—Oedema—Ethinyl Estradiol—osteoporosis	0.000587	0.00282	CcSEcCtD
Thioridazine—Erythema—Conjugated Estrogens—osteoporosis	0.000586	0.00281	CcSEcCtD
Thioridazine—Jaundice—Estradiol—osteoporosis	0.000585	0.00281	CcSEcCtD
Thioridazine—Constipation—Calcitriol—osteoporosis	0.000581	0.00279	CcSEcCtD
Thioridazine—Vision blurred—Zoledronate—osteoporosis	0.000574	0.00275	CcSEcCtD
Thioridazine—Diarrhoea—Etidronic acid—osteoporosis	0.000573	0.00275	CcSEcCtD
Thioridazine—Body temperature increased—Estropipate—osteoporosis	0.000572	0.00275	CcSEcCtD
Thioridazine—Feeling abnormal—Ibandronate—osteoporosis	0.000572	0.00275	CcSEcCtD
Thioridazine—Tremor—Zoledronate—osteoporosis	0.00057	0.00274	CcSEcCtD
Thioridazine—Body temperature increased—Alendronate—osteoporosis	0.000564	0.00271	CcSEcCtD
Thioridazine—Anaemia—Zoledronate—osteoporosis	0.000563	0.0027	CcSEcCtD
Thioridazine—Agitation—Zoledronate—osteoporosis	0.00056	0.00269	CcSEcCtD
Thioridazine—Angioedema—Zoledronate—osteoporosis	0.000556	0.00267	CcSEcCtD
Thioridazine—Body temperature increased—Raloxifene—osteoporosis	0.000555	0.00266	CcSEcCtD
Thioridazine—Vision blurred—Conjugated Estrogens—osteoporosis	0.000553	0.00265	CcSEcCtD
Thioridazine—Body temperature increased—Ibandronate—osteoporosis	0.000549	0.00263	CcSEcCtD
Thioridazine—Confusional state—Pamidronate—osteoporosis	0.000549	0.00263	CcSEcCtD
Thioridazine—Leukopenia—Zoledronate—osteoporosis	0.000545	0.00262	CcSEcCtD
Thioridazine—Oedema—Pamidronate—osteoporosis	0.000544	0.00261	CcSEcCtD
Thioridazine—Body temperature increased—Calcitriol—osteoporosis	0.000537	0.00258	CcSEcCtD
Thioridazine—Angioedema—Conjugated Estrogens—osteoporosis	0.000536	0.00257	CcSEcCtD
Thioridazine—Hypersensitivity—Estropipate—osteoporosis	0.000534	0.00256	CcSEcCtD
Thioridazine—Thrombocytopenia—Pamidronate—osteoporosis	0.000533	0.00256	CcSEcCtD
Thioridazine—Vomiting—Etidronic acid—osteoporosis	0.000532	0.00255	CcSEcCtD
Thioridazine—Oedema peripheral—Estradiol—osteoporosis	0.000531	0.00255	CcSEcCtD
Thioridazine—Tachycardia—Pamidronate—osteoporosis	0.000531	0.00255	CcSEcCtD
Thioridazine—Rash—Etidronic acid—osteoporosis	0.000528	0.00253	CcSEcCtD
Thioridazine—Dermatitis—Etidronic acid—osteoporosis	0.000527	0.00253	CcSEcCtD
Thioridazine—Hyperhidrosis—Pamidronate—osteoporosis	0.000526	0.00252	CcSEcCtD
Thioridazine—Hypersensitivity—Alendronate—osteoporosis	0.000525	0.00252	CcSEcCtD
Thioridazine—Headache—Etidronic acid—osteoporosis	0.000524	0.00252	CcSEcCtD
Thioridazine—Anorexia—Pamidronate—osteoporosis	0.000519	0.00249	CcSEcCtD
Thioridazine—Hypersensitivity—Ibandronate—osteoporosis	0.000512	0.00246	CcSEcCtD
Thioridazine—Hypotension—Pamidronate—osteoporosis	0.000508	0.00244	CcSEcCtD
Thioridazine—Constipation—Ethinyl Estradiol—osteoporosis	0.000502	0.00241	CcSEcCtD
Thioridazine—Confusional state—Zoledronate—osteoporosis	0.000501	0.0024	CcSEcCtD
Thioridazine—Hypersensitivity—Calcitriol—osteoporosis	0.000501	0.0024	CcSEcCtD
Thioridazine—Nausea—Etidronic acid—osteoporosis	0.000497	0.00239	CcSEcCtD
Thioridazine—Oedema—Zoledronate—osteoporosis	0.000497	0.00238	CcSEcCtD
Thioridazine—Diarrhoea—Estropipate—osteoporosis	0.000495	0.00238	CcSEcCtD
Thioridazine—Constipation—Risedronate—osteoporosis	0.000489	0.00235	CcSEcCtD
Thioridazine—Diarrhoea—Alendronate—osteoporosis	0.000488	0.00234	CcSEcCtD
Thioridazine—Thrombocytopenia—Zoledronate—osteoporosis	0.000487	0.00233	CcSEcCtD
Thioridazine—Tachycardia—Zoledronate—osteoporosis	0.000485	0.00233	CcSEcCtD
Thioridazine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000484	0.00232	CcSEcCtD
Thioridazine—Somnolence—Pamidronate—osteoporosis	0.000484	0.00232	CcSEcCtD
Thioridazine—Hyperhidrosis—Zoledronate—osteoporosis	0.00048	0.00231	CcSEcCtD
Thioridazine—Diarrhoea—Raloxifene—osteoporosis	0.00048	0.0023	CcSEcCtD
Thioridazine—Oedema—Conjugated Estrogens—osteoporosis	0.000478	0.0023	CcSEcCtD
Thioridazine—Diarrhoea—Ibandronate—osteoporosis	0.000475	0.00228	CcSEcCtD
Thioridazine—Anorexia—Zoledronate—osteoporosis	0.000474	0.00227	CcSEcCtD
Thioridazine—Decreased appetite—Pamidronate—osteoporosis	0.000473	0.00227	CcSEcCtD
Thioridazine—Mental disorder—Estradiol—osteoporosis	0.000472	0.00227	CcSEcCtD
Thioridazine—Erythema—Estradiol—osteoporosis	0.000469	0.00225	CcSEcCtD
Thioridazine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000467	0.00224	CcSEcCtD
Thioridazine—Constipation—Pamidronate—osteoporosis	0.000465	0.00223	CcSEcCtD
Thioridazine—Diarrhoea—Calcitriol—osteoporosis	0.000465	0.00223	CcSEcCtD
Thioridazine—Hypotension—Zoledronate—osteoporosis	0.000464	0.00223	CcSEcCtD
Thioridazine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000464	0.00223	CcSEcCtD
Thioridazine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000463	0.00222	CcSEcCtD
Thioridazine—Vomiting—Estropipate—osteoporosis	0.00046	0.00221	CcSEcCtD
Thioridazine—Rash—Estropipate—osteoporosis	0.000457	0.00219	CcSEcCtD
Thioridazine—Dermatitis—Estropipate—osteoporosis	0.000456	0.00219	CcSEcCtD
Thioridazine—Anorexia—Conjugated Estrogens—osteoporosis	0.000456	0.00219	CcSEcCtD
Thioridazine—Headache—Estropipate—osteoporosis	0.000454	0.00218	CcSEcCtD
Thioridazine—Vomiting—Alendronate—osteoporosis	0.000453	0.00218	CcSEcCtD
Thioridazine—Body temperature increased—Risedronate—osteoporosis	0.000452	0.00217	CcSEcCtD
Thioridazine—Rash—Alendronate—osteoporosis	0.00045	0.00216	CcSEcCtD
Thioridazine—Dermatitis—Alendronate—osteoporosis	0.000449	0.00216	CcSEcCtD
Thioridazine—Feeling abnormal—Pamidronate—osteoporosis	0.000448	0.00215	CcSEcCtD
Thioridazine—Hypotension—Conjugated Estrogens—osteoporosis	0.000447	0.00215	CcSEcCtD
Thioridazine—Headache—Alendronate—osteoporosis	0.000447	0.00214	CcSEcCtD
Thioridazine—Vomiting—Raloxifene—osteoporosis	0.000446	0.00214	CcSEcCtD
Thioridazine—Rash—Raloxifene—osteoporosis	0.000442	0.00212	CcSEcCtD
Thioridazine—Dermatitis—Raloxifene—osteoporosis	0.000442	0.00212	CcSEcCtD
Thioridazine—Somnolence—Zoledronate—osteoporosis	0.000442	0.00212	CcSEcCtD
Thioridazine—Vomiting—Ibandronate—osteoporosis	0.000442	0.00212	CcSEcCtD
Thioridazine—Tremor—Estradiol—osteoporosis	0.00044	0.00211	CcSEcCtD
Thioridazine—Headache—Raloxifene—osteoporosis	0.000439	0.00211	CcSEcCtD
Thioridazine—Rash—Ibandronate—osteoporosis	0.000438	0.0021	CcSEcCtD
Thioridazine—Dermatitis—Ibandronate—osteoporosis	0.000437	0.0021	CcSEcCtD
Thioridazine—Headache—Ibandronate—osteoporosis	0.000435	0.00209	CcSEcCtD
Thioridazine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000432	0.00208	CcSEcCtD
Thioridazine—Vomiting—Calcitriol—osteoporosis	0.000432	0.00207	CcSEcCtD
Thioridazine—Decreased appetite—Zoledronate—osteoporosis	0.000432	0.00207	CcSEcCtD
Thioridazine—Agitation—Estradiol—osteoporosis	0.000431	0.00207	CcSEcCtD
Thioridazine—Nausea—Estropipate—osteoporosis	0.00043	0.00206	CcSEcCtD
Thioridazine—Body temperature increased—Pamidronate—osteoporosis	0.00043	0.00206	CcSEcCtD
Thioridazine—Angioedema—Estradiol—osteoporosis	0.000429	0.00206	CcSEcCtD
Thioridazine—Rash—Calcitriol—osteoporosis	0.000429	0.00206	CcSEcCtD
Thioridazine—Dermatitis—Calcitriol—osteoporosis	0.000428	0.00205	CcSEcCtD
Thioridazine—Headache—Calcitriol—osteoporosis	0.000426	0.00204	CcSEcCtD
Thioridazine—Somnolence—Conjugated Estrogens—osteoporosis	0.000425	0.00204	CcSEcCtD
Thioridazine—Constipation—Zoledronate—osteoporosis	0.000425	0.00204	CcSEcCtD
Thioridazine—Nausea—Alendronate—osteoporosis	0.000424	0.00203	CcSEcCtD
Thioridazine—Hypersensitivity—Risedronate—osteoporosis	0.000422	0.00202	CcSEcCtD
Thioridazine—Nausea—Raloxifene—osteoporosis	0.000417	0.002	CcSEcCtD
Thioridazine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000416	0.002	CcSEcCtD
Thioridazine—Nausea—Ibandronate—osteoporosis	0.000412	0.00198	CcSEcCtD
Thioridazine—Feeling abnormal—Zoledronate—osteoporosis	0.000409	0.00197	CcSEcCtD
Thioridazine—Constipation—Conjugated Estrogens—osteoporosis	0.000409	0.00196	CcSEcCtD
Thioridazine—Nausea—Calcitriol—osteoporosis	0.000404	0.00194	CcSEcCtD
Thioridazine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000402	0.00193	CcSEcCtD
Thioridazine—Hypersensitivity—Pamidronate—osteoporosis	0.000401	0.00192	CcSEcCtD
Thioridazine—Body temperature increased—Zoledronate—osteoporosis	0.000393	0.00189	CcSEcCtD
Thioridazine—Diarrhoea—Risedronate—osteoporosis	0.000392	0.00188	CcSEcCtD
Thioridazine—Confusional state—Estradiol—osteoporosis	0.000386	0.00185	CcSEcCtD
Thioridazine—Oedema—Estradiol—osteoporosis	0.000383	0.00184	CcSEcCtD
Thioridazine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000378	0.00182	CcSEcCtD
Thioridazine—Tachycardia—Estradiol—osteoporosis	0.000374	0.00179	CcSEcCtD
Thioridazine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000373	0.00179	CcSEcCtD
Thioridazine—Diarrhoea—Pamidronate—osteoporosis	0.000372	0.00179	CcSEcCtD
Thioridazine—Hyperhidrosis—Estradiol—osteoporosis	0.00037	0.00178	CcSEcCtD
Thioridazine—Rash—Ethinyl Estradiol—osteoporosis	0.00037	0.00178	CcSEcCtD
Thioridazine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00037	0.00177	CcSEcCtD
Thioridazine—Headache—Ethinyl Estradiol—osteoporosis	0.000368	0.00176	CcSEcCtD
Thioridazine—Hypersensitivity—Zoledronate—osteoporosis	0.000366	0.00176	CcSEcCtD
Thioridazine—Vomiting—Risedronate—osteoporosis	0.000364	0.00175	CcSEcCtD
Thioridazine—Rash—Risedronate—osteoporosis	0.000361	0.00173	CcSEcCtD
Thioridazine—Dermatitis—Risedronate—osteoporosis	0.00036	0.00173	CcSEcCtD
Thioridazine—Headache—Risedronate—osteoporosis	0.000359	0.00172	CcSEcCtD
Thioridazine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000353	0.00169	CcSEcCtD
Thioridazine—Nausea—Ethinyl Estradiol—osteoporosis	0.000349	0.00167	CcSEcCtD
Thioridazine—Vomiting—Pamidronate—osteoporosis	0.000346	0.00166	CcSEcCtD
Thioridazine—Rash—Pamidronate—osteoporosis	0.000343	0.00165	CcSEcCtD
Thioridazine—Dermatitis—Pamidronate—osteoporosis	0.000343	0.00164	CcSEcCtD
Thioridazine—Headache—Pamidronate—osteoporosis	0.000341	0.00164	CcSEcCtD
Thioridazine—Somnolence—Estradiol—osteoporosis	0.00034	0.00163	CcSEcCtD
Thioridazine—Diarrhoea—Zoledronate—osteoporosis	0.00034	0.00163	CcSEcCtD
Thioridazine—Nausea—Risedronate—osteoporosis	0.00034	0.00163	CcSEcCtD
Thioridazine—Decreased appetite—Estradiol—osteoporosis	0.000333	0.0016	CcSEcCtD
Thioridazine—Constipation—Estradiol—osteoporosis	0.000327	0.00157	CcSEcCtD
Thioridazine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000327	0.00157	CcSEcCtD
Thioridazine—Nausea—Pamidronate—osteoporosis	0.000323	0.00155	CcSEcCtD
Thioridazine—Vomiting—Zoledronate—osteoporosis	0.000316	0.00152	CcSEcCtD
Thioridazine—Feeling abnormal—Estradiol—osteoporosis	0.000316	0.00151	CcSEcCtD
Thioridazine—Rash—Zoledronate—osteoporosis	0.000313	0.0015	CcSEcCtD
Thioridazine—Dermatitis—Zoledronate—osteoporosis	0.000313	0.0015	CcSEcCtD
Thioridazine—Headache—Zoledronate—osteoporosis	0.000311	0.00149	CcSEcCtD
Thioridazine—Vomiting—Conjugated Estrogens—osteoporosis	0.000304	0.00146	CcSEcCtD
Thioridazine—Body temperature increased—Estradiol—osteoporosis	0.000303	0.00145	CcSEcCtD
Thioridazine—Rash—Conjugated Estrogens—osteoporosis	0.000302	0.00145	CcSEcCtD
Thioridazine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000301	0.00145	CcSEcCtD
Thioridazine—Headache—Conjugated Estrogens—osteoporosis	0.0003	0.00144	CcSEcCtD
Thioridazine—Nausea—Zoledronate—osteoporosis	0.000295	0.00142	CcSEcCtD
Thioridazine—Nausea—Conjugated Estrogens—osteoporosis	0.000284	0.00136	CcSEcCtD
Thioridazine—Hypersensitivity—Estradiol—osteoporosis	0.000282	0.00135	CcSEcCtD
Thioridazine—Diarrhoea—Estradiol—osteoporosis	0.000262	0.00126	CcSEcCtD
Thioridazine—Vomiting—Estradiol—osteoporosis	0.000243	0.00117	CcSEcCtD
Thioridazine—Rash—Estradiol—osteoporosis	0.000241	0.00116	CcSEcCtD
Thioridazine—Dermatitis—Estradiol—osteoporosis	0.000241	0.00116	CcSEcCtD
Thioridazine—Headache—Estradiol—osteoporosis	0.00024	0.00115	CcSEcCtD
Thioridazine—Nausea—Estradiol—osteoporosis	0.000227	0.00109	CcSEcCtD
Thioridazine—CYP1A2—Metabolism—CYP27A1—osteoporosis	1.95e-05	0.000211	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—IL6R—osteoporosis	1.95e-05	0.000211	CbGpPWpGaD
Thioridazine—DRD2—GPCR downstream signaling—POMC—osteoporosis	1.94e-05	0.00021	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—P4HB—osteoporosis	1.94e-05	0.00021	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CALCA—osteoporosis	1.92e-05	0.000208	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—GAPDH—osteoporosis	1.92e-05	0.000208	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CALCA—osteoporosis	1.92e-05	0.000207	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—POMC—osteoporosis	1.91e-05	0.000207	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—PSMA2—osteoporosis	1.91e-05	0.000207	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—PSMA5—osteoporosis	1.91e-05	0.000207	CbGpPWpGaD
Thioridazine—HTR2A—GPCR downstream signaling—POMC—osteoporosis	1.91e-05	0.000207	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—POMC—osteoporosis	1.91e-05	0.000206	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—IRS2—osteoporosis	1.91e-05	0.000206	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—GAPDH—osteoporosis	1.9e-05	0.000206	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—IRS2—osteoporosis	1.9e-05	0.000206	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—ACP5—osteoporosis	1.9e-05	0.000205	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—POMC—osteoporosis	1.87e-05	0.000203	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—ADCY5—osteoporosis	1.87e-05	0.000203	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.87e-05	0.000203	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—RAP1A—osteoporosis	1.87e-05	0.000202	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—POMC—osteoporosis	1.87e-05	0.000202	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—IL6R—osteoporosis	1.86e-05	0.000202	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—LEP—osteoporosis	1.86e-05	0.000202	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—LEP—osteoporosis	1.86e-05	0.000202	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—CYP19A1—osteoporosis	1.85e-05	0.000201	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—RAP1A—osteoporosis	1.85e-05	0.000201	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—ENO1—osteoporosis	1.84e-05	0.000199	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PSMA2—osteoporosis	1.81e-05	0.000196	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PSMA5—osteoporosis	1.81e-05	0.000196	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—SPP1—osteoporosis	1.81e-05	0.000196	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—KL—osteoporosis	1.81e-05	0.000196	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CALCA—osteoporosis	1.78e-05	0.000193	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—ESR1—osteoporosis	1.78e-05	0.000193	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—ESR1—osteoporosis	1.78e-05	0.000192	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—KL—osteoporosis	1.78e-05	0.000192	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—KL—osteoporosis	1.77e-05	0.000192	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.77e-05	0.000192	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—TPI1—osteoporosis	1.76e-05	0.000191	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—POMC—osteoporosis	1.76e-05	0.000191	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—KL—osteoporosis	1.75e-05	0.000189	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—KL—osteoporosis	1.74e-05	0.000188	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—POMC—osteoporosis	1.74e-05	0.000188	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—POMC—osteoporosis	1.73e-05	0.000188	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—POMC—osteoporosis	1.73e-05	0.000187	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—IL6R—osteoporosis	1.72e-05	0.000186	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—CYP19A1—osteoporosis	1.7e-05	0.000184	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—POMC—osteoporosis	1.7e-05	0.000184	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—POMC—osteoporosis	1.7e-05	0.000184	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—IL6R—osteoporosis	1.69e-05	0.000183	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—IL6R—osteoporosis	1.69e-05	0.000183	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—IRS1—osteoporosis	1.66e-05	0.00018	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—IRS1—osteoporosis	1.66e-05	0.00018	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—IL6R—osteoporosis	1.66e-05	0.00018	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—P4HB—osteoporosis	1.66e-05	0.000179	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—IL6R—osteoporosis	1.66e-05	0.000179	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—ENO1—osteoporosis	1.64e-05	0.000178	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—IRS2—osteoporosis	1.64e-05	0.000177	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—GAPDH—osteoporosis	1.63e-05	0.000176	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PSMA2—osteoporosis	1.62e-05	0.000175	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PSMA5—osteoporosis	1.62e-05	0.000175	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—KL—osteoporosis	1.62e-05	0.000175	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.62e-05	0.000175	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—ADCY5—osteoporosis	1.61e-05	0.000174	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—LEP—osteoporosis	1.61e-05	0.000174	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—ADCY5—osteoporosis	1.6e-05	0.000174	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—POMC—osteoporosis	1.6e-05	0.000173	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—POMC—osteoporosis	1.6e-05	0.000173	CbGpPWpGaD
Thioridazine—ADRA2A—Hemostasis—TGFB1—osteoporosis	1.59e-05	0.000172	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—RAP1A—osteoporosis	1.58e-05	0.000171	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—POMC—osteoporosis	1.58e-05	0.000171	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—IL6R—osteoporosis	1.56e-05	0.000169	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—IL6R—osteoporosis	1.56e-05	0.000169	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—SPP1—osteoporosis	1.56e-05	0.000169	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—SPP1—osteoporosis	1.55e-05	0.000168	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—IGF1—osteoporosis	1.54e-05	0.000167	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—IGF1—osteoporosis	1.54e-05	0.000167	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—IL6R—osteoporosis	1.54e-05	0.000167	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—ADCY5—osteoporosis	1.54e-05	0.000166	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—ESR1—osteoporosis	1.53e-05	0.000166	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—ADCY5—osteoporosis	1.52e-05	0.000164	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—ENO1—osteoporosis	1.51e-05	0.000164	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—GPX1—osteoporosis	1.51e-05	0.000163	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—ENO1—osteoporosis	1.5e-05	0.000162	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PSMA5—osteoporosis	1.49e-05	0.000161	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PSMA2—osteoporosis	1.49e-05	0.000161	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—SPP1—osteoporosis	1.49e-05	0.000161	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PSMA5—osteoporosis	1.48e-05	0.00016	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PSMA2—osteoporosis	1.48e-05	0.00016	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—CYP19A1—osteoporosis	1.47e-05	0.000159	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—IRS1—osteoporosis	1.43e-05	0.000155	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—ADCY5—osteoporosis	1.42e-05	0.000153	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—IRS2—osteoporosis	1.41e-05	0.000153	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—IRS2—osteoporosis	1.4e-05	0.000152	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—MTHFR—osteoporosis	1.39e-05	0.000151	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—ADCY5—osteoporosis	1.39e-05	0.000151	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—ADCY5—osteoporosis	1.39e-05	0.000151	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—ADCY5—osteoporosis	1.39e-05	0.00015	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—GPX1—osteoporosis	1.39e-05	0.00015	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.38e-05	0.000149	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—LEP—osteoporosis	1.38e-05	0.000149	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—POMC—osteoporosis	1.38e-05	0.000149	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—LEP—osteoporosis	1.37e-05	0.000149	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—SPP1—osteoporosis	1.37e-05	0.000148	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—ADCY5—osteoporosis	1.37e-05	0.000148	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—ADCY5—osteoporosis	1.36e-05	0.000148	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—SPP1—osteoporosis	1.35e-05	0.000146	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—IL6R—osteoporosis	1.35e-05	0.000146	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—SPP1—osteoporosis	1.34e-05	0.000145	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—IRS2—osteoporosis	1.34e-05	0.000145	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—IGF1—osteoporosis	1.33e-05	0.000144	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—SPP1—osteoporosis	1.32e-05	0.000143	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—SPP1—osteoporosis	1.32e-05	0.000143	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—ESR1—osteoporosis	1.32e-05	0.000143	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—LEP—osteoporosis	1.31e-05	0.000142	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—CYP19A1—osteoporosis	1.31e-05	0.000142	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—ESR1—osteoporosis	1.31e-05	0.000142	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—ENO1—osteoporosis	1.28e-05	0.000139	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—MTHFR—osteoporosis	1.28e-05	0.000138	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—ADCY5—osteoporosis	1.27e-05	0.000137	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PSMA5—osteoporosis	1.26e-05	0.000137	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PSMA2—osteoporosis	1.26e-05	0.000137	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—ESR1—osteoporosis	1.25e-05	0.000136	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—IRS2—osteoporosis	1.24e-05	0.000134	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—IRS1—osteoporosis	1.23e-05	0.000133	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—SPP1—osteoporosis	1.23e-05	0.000133	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—IRS1—osteoporosis	1.22e-05	0.000133	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—IRS2—osteoporosis	1.22e-05	0.000132	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—IRS2—osteoporosis	1.22e-05	0.000132	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—LEP—osteoporosis	1.21e-05	0.000131	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—CYP19A1—osteoporosis	1.21e-05	0.000131	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—ADCY5—osteoporosis	1.2e-05	0.00013	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—GPX1—osteoporosis	1.2e-05	0.00013	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—CYP19A1—osteoporosis	1.2e-05	0.00013	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—IRS2—osteoporosis	1.2e-05	0.000129	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—IRS2—osteoporosis	1.19e-05	0.000129	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—LEP—osteoporosis	1.19e-05	0.000129	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—LEP—osteoporosis	1.19e-05	0.000129	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—POMC—osteoporosis	1.19e-05	0.000128	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—POMC—osteoporosis	1.18e-05	0.000128	CbGpPWpGaD
Thioridazine—HTR6—Signaling by GPCR—IL6—osteoporosis	1.18e-05	0.000127	CbGpPWpGaD
Thioridazine—HTR7—Signaling by GPCR—IL6—osteoporosis	1.18e-05	0.000127	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—IRS1—osteoporosis	1.17e-05	0.000127	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—LEP—osteoporosis	1.17e-05	0.000127	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—LEP—osteoporosis	1.17e-05	0.000126	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—ESR1—osteoporosis	1.16e-05	0.000125	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—IL6R—osteoporosis	1.16e-05	0.000125	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—IL6R—osteoporosis	1.15e-05	0.000125	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—IGF1—osteoporosis	1.14e-05	0.000123	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—ESR1—osteoporosis	1.14e-05	0.000123	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—ESR1—osteoporosis	1.14e-05	0.000123	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—IGF1—osteoporosis	1.13e-05	0.000123	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—POMC—osteoporosis	1.13e-05	0.000122	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—ESR1—osteoporosis	1.12e-05	0.000121	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—ESR1—osteoporosis	1.11e-05	0.000121	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—POMC—osteoporosis	1.11e-05	0.000121	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—IRS2—osteoporosis	1.11e-05	0.00012	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—MTHFR—osteoporosis	1.11e-05	0.00012	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—IL6R—osteoporosis	1.1e-05	0.000119	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—IGF1—osteoporosis	1.09e-05	0.000118	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—LEP—osteoporosis	1.08e-05	0.000117	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—IRS1—osteoporosis	1.08e-05	0.000117	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—ADCY5—osteoporosis	1.07e-05	0.000116	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—GPX1—osteoporosis	1.07e-05	0.000116	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—IRS1—osteoporosis	1.06e-05	0.000115	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—IRS1—osteoporosis	1.06e-05	0.000115	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—IRS1—osteoporosis	1.04e-05	0.000113	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—IRS1—osteoporosis	1.04e-05	0.000113	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—POMC—osteoporosis	1.04e-05	0.000113	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—ESR1—osteoporosis	1.04e-05	0.000112	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—POMC—osteoporosis	1.02e-05	0.000111	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—CYP19A1—osteoporosis	1.02e-05	0.000111	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—POMC—osteoporosis	1.02e-05	0.000111	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—POMC—osteoporosis	1.02e-05	0.000111	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—IL6R—osteoporosis	1.02e-05	0.00011	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—IL6—osteoporosis	1.01e-05	0.00011	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—POMC—osteoporosis	1.01e-05	0.000109	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—POMC—osteoporosis	1e-05	0.000109	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—IGF1—osteoporosis	1e-05	0.000108	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—IL6R—osteoporosis	9.99e-06	0.000108	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—IL6R—osteoporosis	9.97e-06	0.000108	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—ADCY5—osteoporosis	9.87e-06	0.000107	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—MTHFR—osteoporosis	9.87e-06	0.000107	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—IGF1—osteoporosis	9.85e-06	0.000107	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—GPX1—osteoporosis	9.84e-06	0.000106	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—IGF1—osteoporosis	9.83e-06	0.000106	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—IL6R—osteoporosis	9.81e-06	0.000106	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—ADCY5—osteoporosis	9.79e-06	0.000106	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—IL6R—osteoporosis	9.78e-06	0.000106	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—GPX1—osteoporosis	9.75e-06	0.000106	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—IRS1—osteoporosis	9.68e-06	0.000105	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—IGF1—osteoporosis	9.67e-06	0.000105	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—IGF1—osteoporosis	9.65e-06	0.000104	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—POMC—osteoporosis	9.32e-06	0.000101	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—MYC—osteoporosis	9.26e-06	0.0001	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—MYC—osteoporosis	9.25e-06	0.0001	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—TGFB1—osteoporosis	9.24e-06	9.99e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—TGFB1—osteoporosis	9.23e-06	9.98e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—IL6R—osteoporosis	9.09e-06	9.84e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—MTHFR—osteoporosis	9.08e-06	9.83e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—MTHFR—osteoporosis	9e-06	9.74e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—IGF1—osteoporosis	8.96e-06	9.7e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—POMC—osteoporosis	8.85e-06	9.57e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—IL6—osteoporosis	8.72e-06	9.44e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—IL6—osteoporosis	8.68e-06	9.39e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—ADCY5—osteoporosis	8.36e-06	9.05e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—GPX1—osteoporosis	8.34e-06	9.02e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—IL6—osteoporosis	8.31e-06	8.99e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—MYC—osteoporosis	7.97e-06	8.62e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—TGFB1—osteoporosis	7.95e-06	8.6e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—POMC—osteoporosis	7.9e-06	8.54e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—MTHFR—osteoporosis	7.69e-06	8.32e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—IL6—osteoporosis	7.66e-06	8.29e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—IL6—osteoporosis	7.54e-06	8.15e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—IL6—osteoporosis	7.52e-06	8.14e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—IL6—osteoporosis	7.4e-06	8.01e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—IL6—osteoporosis	7.38e-06	7.98e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—POMC—osteoporosis	7.26e-06	7.86e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—POMC—osteoporosis	7.2e-06	7.79e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—IL6—osteoporosis	6.96e-06	7.53e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—IL6—osteoporosis	6.95e-06	7.52e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—IL6—osteoporosis	6.86e-06	7.42e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—MYC—osteoporosis	6.85e-06	7.42e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—TGFB1—osteoporosis	6.84e-06	7.4e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—MYC—osteoporosis	6.82e-06	7.38e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—TGFB1—osteoporosis	6.8e-06	7.36e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—MYC—osteoporosis	6.53e-06	7.06e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—TGFB1—osteoporosis	6.51e-06	7.05e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—POMC—osteoporosis	6.15e-06	6.66e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—MYC—osteoporosis	6.02e-06	6.51e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—TGFB1—osteoporosis	6e-06	6.5e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—IL6—osteoporosis	5.99e-06	6.48e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—MYC—osteoporosis	5.92e-06	6.41e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—MYC—osteoporosis	5.91e-06	6.39e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—TGFB1—osteoporosis	5.91e-06	6.39e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—TGFB1—osteoporosis	5.89e-06	6.38e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—MYC—osteoporosis	5.81e-06	6.29e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—TGFB1—osteoporosis	5.8e-06	6.28e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—MYC—osteoporosis	5.8e-06	6.27e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—TGFB1—osteoporosis	5.78e-06	6.26e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MYC—osteoporosis	5.39e-06	5.83e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—TGFB1—osteoporosis	5.37e-06	5.81e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—IL6—osteoporosis	5.15e-06	5.58e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—IL6—osteoporosis	5.13e-06	5.55e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—IL6—osteoporosis	4.91e-06	5.31e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—IL6—osteoporosis	4.52e-06	4.89e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—IL6—osteoporosis	4.45e-06	4.82e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—IL6—osteoporosis	4.44e-06	4.81e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—IL6—osteoporosis	4.37e-06	4.73e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—IL6—osteoporosis	4.36e-06	4.72e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—IL6—osteoporosis	4.05e-06	4.38e-05	CbGpPWpGaD
